Skip to main content

Table 2 Baseline characteristics of patients with CHD and control subjects

From: Impact of matrix metalloproteinase 9 rs3918242 genetic variant on lipid-lowering efficacy of simvastatin therapy in Chinese patients with coronary heart disease

  Controls (n = 186) CHD group (n = 264)
Sex (M:F) 96: 90 152: 112
Age (years) 58 ± 10.72 59 ± 11.67
Waist (cm) 86.25 ± 6.03 88.11 ± 5.97
Height (cm) 171.28 ± 5.39 169.15 ± 6.62
Weight (kg) 70.04 ± 7.91 71.24 ± 7.35
Body mass index (kg/m2) 23.98 ± 2.93 24.73 ± 2.86
Systolic blood pressure (mmHg) 123 ± 19 125 ± 21
Diastolic blood pressure (mmHg) 60 ± 17 65 ± 18
Heart rate 64 ± 15 67 ± 16
Fasting glucose (mmol/l) 4.35 ± 1.02 4.62 ± 1.31
Smoking 45 (24.19%) 109 (41.23%)*
Alcohol abuse 26 (14.05%) 43 (16.27%)
  1. Data are means ± SD. *P <0.01 compared with control group. CHD coronary heart disease